AB018. Superior mediastinal tumor, distribution of the diseases, and its clinical course
Abstract

AB018. Superior mediastinal tumor, distribution of the diseases, and its clinical course

Takao Nakanishi, Taishi Adachi, Hideki Motoyama, Mitsugu Omasa

Department of Thoracic Surgery, Kobe City Nishi-Kobe Medical Center, Kobe, Japan

Correspondence to: Takao Nakanishi, MD, PhD. Department of Thoracic Surgery, Kobe City Nishi-Kobe Medical Center, 5-7-1 Kojidai, Nishi-ku, Kobe 6512273, Japan. Email: takawonak1@gmx.com.

Background: Thymomas originating from the superior mediastinum (cephalad to the left brachiocephalic vein) are relatively rare and reported to have a poorer prognosis. The four-compartment classification model, which includes the superior portion of the mediastinum, has the advantages of “sufficient separation of disease distribution” and “differentiation of prognosis of thymic epithelial tumors (TETs) by tumor location”. We aimed to validate these advantages using our clinical data.

Methods: We retrospectively reviewed the patients who underwent therapeutic resection of anterior/superior mediastinum tumors at Nishi-Kobe Medical Center from 1 January 2017 to 31 March 2024. We evaluated the location of the tumors, the surgical procedure, the clinicopathological features, and the patients’ survival outcomes. The compartment’s boundaries were defined according to the Japanese Association for Research on the Thymus (JART) general rules.

Results: A total of 84 patients were eligible for this study. Thyroid tumors (superior 3: anterior 0, P=0.002) and schwannomas (2:0, P=0.02) were specific to the superior mediastinum group (n=11), compared with the anterior mediastinum group (n=73). Meanwhile, the proportion of TETs (Sup 3: Ant 39, P=0.19) and cysts (3:28, P=0.74) were not distinctive. In the TETs group (n=42), the breakdown of diseases [thymoma with myasthenia gravis (MG), Sup 0: Ant 12; thymoma without MG, 2:13; thymic cancer, 1:4] was not different by the location. The open procedures were common (Sup, median sternotomy: trans-manubrial: thoracoscopic =1:1:1; Ant, 10:0:29, P=0.048), R1 resection was frequent (Sup: 66%; Ant: 10%, P=0.09), and the prognosis was poorer (2-year disease-free survival, Sup, 0.5; Ant, 0.927, P=0.007) in superior mediastinum group, whereas the tumor size (Sup, 46.7 mm; Ant, 48.9 mm, P=0.88), and pT factor (Sup, T1:T2:T3 =2:0:1; Ant, 31:3:3, P=0.45) were similar.

Conclusions: While International Thymic Malignancy Interest Group (ITMIG) classification of mediastinal compartment did not distinguish superior mediastinum, the four-compartment classification proposed by JART which includes a superior portion, was useful in recalling the specific disease (thyroid tumor, etc.) and supposing the difficulty of resection or the prognosis of TETs.

Keywords: Superior mediastinum; Japanese Association for Research on the Thymus (JART); four-compartment classification


Acknowledgments

Funding: None.


Footnote

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://med.amegroups.com/article/view/10.21037/med-24-ab018/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the institutional ethics board of Kobe City Nishi-Kobe Medical Center (No. 2024-23) and individual consent for this retrospective analysis was waived.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


doi: 10.21037/med-24-ab018
Cite this abstract as: Nakanishi T, Adachi T, Motoyama H, Omasa M. AB018. Superior mediastinal tumor, distribution of the diseases, and its clinical course. Mediastinum 2024;8:AB018.

Download Citation